Gil Beyen founded TiGenix NV. Presently, Mr. Beyen occupies the position of Chief Executive Officer & Director at ERYTech Pharma SA, President for Erytech Pharma, Inc. and Co-Managing Director at Axxis V&C BVBA.

He is also Commissioner of Vlaams Instituut voor Biotechnologie - Flanders Institute and on the board of 5 other companies.

In his past career Mr. Beyen held the position of Head-Life Sciences Division at Arthur D. Little, Inc. and Head-Life Sciences Division at Arthur D. Little Benelux NV (a subsidiary of Arthur D. Little, Inc.), MD, Executive Director & Chief Business Officer at TiGenix NV and Manager at Gil Beyen BVBA.

Mr. Beyen received an MBA from The University of Chicago, a graduate degree from Université Catholique de Louvain and a graduate degree from Katholieke Universiteit Leuven.